Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer

The Sequence Alignment/Map format and SAMtools

2009 • 54,537 citations

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

2010 • 24,159 citations

Molecular portraits of human breast tumours

2000 • 15,445 citations

Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer

2013 • 12,861 citations

Cancer statistics, 2015

2015 • 11,660 citations

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

2012 • 7,135 citations

Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer

2004 • 5,439 citations

Ki67 expression in breast cancer

2016 • 4,269 citations

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

2012 • 4,238 citations

Abiraterone and Increased Survival in Metastatic Prostate Cancer

2011 • 4,070 citations

Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer

2005 • 3,714 citations

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr–Abl positive cells

1996 • 3,649 citations

Integrative Genomic Profiling of Human Prostate Cancer

2010 • 3,485 citations

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1941 • 3,235 citations

Integrative Clinical Genomics of Advanced Prostate Cancer

2015 • 3,212 citations

The Molecular Taxonomy of Primary Prostate Cancer

2015 • 2,776 citations

The mutational landscape of lethal castration-resistant prostate cancer

2012 • 2,378 citations

Distant metastasis occurs late during the genetic evolution of pancreatic cancer

2010 • 2,359 citations

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

2015 • 1,985 citations

Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer

2012 • 1,433 citations

The evolutionary history of lethal metastatic prostate cancer

2015 • 1,314 citations

Integrated molecular analysis of clear-cell renal cell carcinoma

2013 • 1,085 citations

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

2014 • 1,035 citations

Glucocorticoid Receptor Confers Resistance to Antiandrogens by Bypassing Androgen Receptor Blockade

2013 • 911 citations

Intratumor heterogeneity in localized lung adenocarcinomas delineated by multiregion sequencing

2014 • 897 citations

Prognostic value of an RNA expression signature derived from cell cycle proliferation genes in patients with prostate cancer: a retrospective study

2011 • 718 citations

High grade prostatic intraepithelial neoplasia (HGPIN) and prostatic adenocarcinoma between the ages of 20-69: an autopsy study of 249 cases.

1994 • 573 citations

Prognostically relevant gene signatures of high-grade serous ovarian carcinoma

2012 • 564 citations

The integrated landscape of driver genomic alterations in glioblastoma

2013 • 505 citations

Tracking the clonal origin of lethal prostate cancer

2013 • 478 citations

Analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue

2015 • 416 citations

Clonal selection drives genetic divergence of metastatic medulloblastoma

2012 • 387 citations

Lineage dependency and lineage-survival oncogenes in human cancer

2006 • 338 citations

Estrogen-Dependent Signaling in a Molecularly Distinct Subclass of Aggressive Prostate Cancer

2008 • 329 citations

Copy number alteration burden predicts prostate cancer relapse

2014 • 328 citations

Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone

2003 • 309 citations

Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma

2013 • 304 citations

Exome sequencing identifies a spectrum of mutation frequencies in advanced and lethal prostate cancers

2011 • 260 citations

DNA Methylation Alterations Exhibit Intraindividual Stability and Interindividual Heterogeneity in Prostate Cancer Metastases

2013 • 255 citations

Progression of LNCaP Prostate Tumor Cells during Androgen Deprivation: Hormone-Independent Growth, Repression of Proliferation by Androgen, and Role for p27Kip1 in Androgen-Induced Cell Cycle Arrest

1998 • 245 citations

Complex MSH2 and MSH6 mutations in hypermutated microsatellite unstable advanced prostate cancer

2014 • 244 citations

Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer

2013 • 235 citations

Effect of bipolar androgen therapy for asymptomatic men with castration-resistant prostate cancer: Results from a pilot clinical study

2015 • 229 citations

Siah2-Dependent Concerted Activity of HIF and FoxA2 Regulates Formation of Neuroendocrine Phenotype and Neuroendocrine Prostate Tumors

2010 • 219 citations

FoxA1 Specifies Unique Androgen and Glucocorticoid Receptor Binding Events in Prostate Cancer Cells

2012 • 219 citations

Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors

2010 • 177 citations

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

2012 • 108 citations

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

2007 • 96 citations

Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone

2009 • 88 citations

Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer

2009 • 32 citations

The Fanconi anemia pathway in replication stress and DNA crosslink repair

2012 • 26 citations

Fanconi Anemia Core Complex Gene Promoters Harbor Conserved Transcription Regulatory Elements

2011 • 19 citations

Mash1 expression is induced in neuroendocrine prostate cancer upon the loss of Foxa2

2012 • 10 citations

Systems biology-based identification of crosstalk between E2F transcription factors and the Fanconi anemia pathway.

2007 • 9 citations